Participant Information


Physical/Onsite conference will take place at the Casino Sinaia , Bulevardul Carol I nr.2, Sinaia
Location website

Online - you will receive the link from the hosting platform on 20th November 2022

Registration Fee:

  • Full participant fee - 250 RON;
  • Discounted young investigator fee (e.g., resident physicians, other related professionals in training) - 50 RON.

The registration fee will be paid until 16th of November 2022, in the account of Asociația "Societatea de Boli Infecțioase și HIV/SIDA", RO54RNCB0078138325900001 - Banca Comercială Română.
The registration fee includes: onsite or virtual participation to the conference scientific program, access to the onsite medical exhibition.

Accommodation: Will be provided only for the presenting author of the accepted oral presentations. If you don't have a presentation please make reservation on the hotel website: Hotel Palace Sinaia.

Proof of tax payment will be sent by e-mail, attached files (pdf or jpg format):

Applicable deadlines:

  • Registration deadline: 15th November 2022;
  • Deadline late breaker abstracts: 1st November 2022 before 18:00 pm;
  • Date for announcing the decision regarding acceptance/rejection and type of presentation by the Scientific Committee: 5 November 2022.
  • Deadline for sending the poster or the recording for accepted oral presentations: 15th November 2022


  • For information regarding organizing: Dana Dobrescu, telephone: (+4) 0761 268 182, email:
  • For technical problems regarding the website and registration process: Claudiu Mihai Șchiopu, mobile phone: (+40) 758 109 172
  • Secretary:


Registration deadline: 15th November 2022

Abstract Acceptance Conditions:

Submitted abstracts should fit into one of the following two categories: 1. Original work or 2. Clinical case.
Abstracts should be related to one of the selected conference topics and should reflect personal research/clinical case or the research/clinical case of the clinic which the participant represents; theoretical/literature review presentations will not be considered for inclusion.
Abstracts should not have been presented or published elsewhere.
The responsibility of the abstract content and of obtaining all institutional approvals belongs to the authors.
For case reports, the authors are also responsible for obtaining consent for publication from the patient/parents/next of kin, prior to abstract submission.
With the exception of one oral session of COVID-19 clinical cases, case reports will only be considered for inclusion as posters.

Accepted oral presentations

For physical/onsite:

Oral presentations should be provided in ppt 2013-2019 format or pptx format. The maximum duration of the presentation should be 7 minutes. Bring your oral presentations on a memory stick on site. No theoretical presentations are admitted (literature review). No case presentations are admitted.

Posters will be displayed on digital support (LED screens). Posters will be displayed in landscape orientation, and should be formatted at a length of 1920 pixels and a height of 1080 pixels. All posters should be PowerPoint presentations (ppt or pptx), in widescreen 16:9 format. Posters will be sent via email to before 15th November 2022.

For online/virtual:

Oral presentations should be provided in pre-recoreded format with voice in PowerPoint 2013-2019 exported in MPEG-4 video. The maximum duration of the presentation should be 5 minutes.
The video file will be sent by e-mail at: before 15th November 2022.
Posters: Posters will be displayed on the event website. Posters will be displayed in landscape orientation. All posters should be PowerPoint presentations (pptx), in widescreen 16:9 format. Posters will be sent by email to before 15th November 2022.

Instructions for writing abstracts:

The abstracts will be written in US English and will include:

  • Title
  • Full names of all authors separated by commas, associated with superscripted affiliations (no abbreviations/initials, no academic or professional titles included);
  • Full institutional affiliation for each author (department, institute, town and country; for multiple affiliations, each should be listed as a separate paragraph)
  • Email address for presenting author
  • Abstract text – structured to include the following sections: for Original work: Introduction, Methods, Results, Conclusions; for Case reports: Introduction, Case report, Conclusions. Paragraph headings should be typed in bold with no colon at the end (the word count for the abstract text should be below 400 words; formatted with single line spacing, unjustified; only SI units should be included; abbreviations should be used as sparingly as possible and should be defined when first used)
  • Acknowledgement (mention here any applicable acknowledgments, conflicts of interest to declare, funding sources, etc.)
  • Consent: For case reports, the authors should mention that consent for publication was obtained from the patient/parents/next of kin.
  • Abstracts for randomized controlled trials should include the trial registry along with the unique identifying number.

Download an abstract template HERE

Tables, Figures and References should be included in the oral or poster presentation rather than in the abstract. If it is absolutely necessary to include any of these elements in the abstract, kindly contact the scientific committee.

Accepted abstracts will be published in English as Conference Proceedings with ISSN. The abstract’s title should also be provided in Romanian, as this version will be included in the final program.

An e-mail address of the presenting authors is required for contact with the conference organizing committee. This email address may also be published online, together with the abstract. Submission of abstracts is considered an acceptance of the above-mentioned terms.